This site is intended for healthcare professionals only
The government’s competition watchdog has accused manufacturer Concordia of over-charging the NHS millions of pounds for a thyroid treatment.
As part of its investigation, the Competition and Markets Authority (CMA) "provisionally" found last year that the pharmaceutical company charged the NHS more than £34 million for liothyronine tablets in 2016 – "an increase from around £600,000" spent on them in 2006, it announced yesterday (November 21).
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.